放射性X射线疗法通过调节交感神经系统和过渡体来影响心脏功能障碍
Justyne Feat-Vetel1, Nadine Suffee2, Florence Bachelot3
1Laboratoire de Pharmacologie Expérimentale et Moléculaire (LPEM), Service d'Ingénierie Moléculaire Pour la Santé (SIMoS), Département Médicaments et Technologies Pour la Santé (DMTS), CEA, 91191 Gif-sur-Yvette, France.
对右侧乳腺癌的低剂量X射线照射可以导致晚期心脏功能障碍和纤维化. 这种放射治疗的副作用涉及到心交感神经系统和处理的变化,可能导致心律失常.
科学领域:
- 心脏病学 心脏病学
- 辐射疗法 辐射疗法
- 分子生物学分子生物学
背景情况:
- 流行病学研究将右侧乳腺癌的放射治疗与心血管疾病联系起来.
- 接受放射治疗 (RT) 的患者患心律失常和导电障碍的风险增加.
研究的目的:
- 研究低至中剂量X射线辐射 (IR) 对心脏功能的机制.
- 评估心交感神经系统 (CSNS) 的变化,心房重塑和IR后的平衡.
- 为了识别乳腺癌的RT期间的亲心律失常机制和潜在的预防策略.
主要方法:
- 雌性C57Bl/6J小鼠接受了X射线剂量 (0.252 Gy),模仿右侧乳腺癌的RT.
- 用多普勒超声波在辐射后60周评估心脏功能.
- 分析了心脏纤维化,亡,过时蛋白质表达和CSNS.
主要成果:
- 低剂量IR (≥0.25 Gy) 诱导晚期心脏和心房功能障碍,心肌应变减小,射出分数和心房功能.
- 在0.5 Gy时观察到显著的表心纤维化和亡.
- 红外线改变了室内CSNS结构和过渡蛋白的表达,影响心脏收缩性,并可能导致心律失常.
结论:
- 当地心脏辐射,即使是低剂量,也可能导致晚期心脏功能障碍和纤维化.
- 辐射引起的CSNS和处理的变化有助于心律障碍.
- 这些发现为预防乳腺癌患者的辐射诱导性心律失常提供了洞察力.
更多相关视频
06:40Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
Published on: May 22, 2018
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
相关概念视频
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
X-ray Imaging
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Pathophysiology of Cardiac Performance
Antihypertensive Drugs: Action of Calcium Channel Blockers
